Back to 
Cantor Fitzgerald, L.P.
Cantor Fitzgerald, L.P.
ANTX
2 quarters
Position history for Cantor Fitzgerald, L.P.'s holdings in AN2 Therapeutics, Inc.
No. Cantor Fitzgerald exited its ANTX (AN2 Therapeutics) position in Q2 2026. Its Q1 2026 13F listed 200,000 shares worth $684,000. Cantor Fitzgerald first reported ANTX in Q1 2026 and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$684,000
Total Shares Change
-200,000
Quarter-by-Quarter History
Other major holders of ANTX: RA Capital Management, L.P.